Recommended Liver Function Tests for Tigecycline Monitoring
Tigecycline, a glycylcycline antibiotic, carries a risk of elevated liver enzymes, prompting routine monitoring of specific liver function tests (LFTs). Guidelines recommend checking ALT (alanine aminotransferase), AST (aspartate aminotransferase), alkaline phosphatase (ALP), and total bilirubin before starting treatment and periodically during therapy, especially in patients with hepatic impairment or prolonged use.[1][2]
Why Monitor These Tests with Tigecycline?
Tigecycline can cause transient increases in liver transaminases (ALT/AST), with elevations >10x upper limit of normal reported in up to 10% of patients in clinical trials. ALP and bilirubin monitoring detects cholestatic patterns or severe hepatotoxicity. The FDA label advises baseline LFTs and weekly checks for complicated intra-abdominal infections or skin infections treated beyond 14 days.[1][3]
How Often Should Tests Be Done?
- Baseline: Before first dose.
- During treatment: At least weekly for courses >7 days; more frequently (e.g., every 3-5 days) if enzymes rise or in liver disease patients.
- Post-treatment: If abnormalities occur, continue until normalization.
Adjust dosing in Child-Pugh C cirrhosis (no adjustment for A/B).[1][2]
What If Tests Show Abnormalities?
Mild elevations (2-5x ULN) often resolve without stopping; >5-10x ULN may require discontinuation. Symptoms like jaundice or fatigue warrant immediate halt and evaluation for other causes (e.g., sepsis, concurrent drugs).[1][3] No specific tigecycline rechallenge protocol exists.
Tigecycline vs. Other Tetracyclines on Liver Impact
Unlike doxycycline (minimal hepatotoxicity), tigecycline has higher LFT elevation rates (15-20% vs. <5%). Minocycline shares some risk but less frequently.[2][4]
Patients at Higher Risk
Those with obesity, diabetes, alcohol use, or IV drug history see more elevations. Pregnancy category D; limited data in pediatrics.[1]
Sources
[1]: Tygacil (tigecycline) FDA Label
[2]: IDSA Guidelines on Complicated Infections
[3]: Drugs.com Tigecycline Monitoring
[4]: Hepatotoxicity of Antibiotics Review - Hepatology